Related Experiment Video

Updated: Apr 28, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

8.9K

Diphenylpyrroles: Novel p53 activators

Sobhi M Gomha1, Taha M A Eldebss1, Mohamed M Abdulla2

  • 1Department of Chemistry, Faculty of Science, Cairo University, Giza 12613, Egypt.

European Journal of Medicinal Chemistry
|June 18, 2014
PubMed

Insights

Researchers developed novel diphenylpyrrole compounds as potential cancer therapeutics. These compounds target HDM2, a protein that inhibits the tumor suppressor p53, thereby reactivating p53

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Oncology

Background:

  • Cellular tumor antigen p53 is vital for cancer prevention.
  • HDM2 negatively regulates p53 by inhibiting its transcriptional activity.
  • Targeting the p53-HDM2 interaction is a promising strategy for developing antitumor agents.

Purpose of the Study:

  • To introduce and evaluate diphenylpyrroles as a novel scaffold for HDM2 antagonists.
  • To explore the potential of these compounds in reactivating p53.
  • To develop efficient synthetic routes for novel 3-heteroaryl-pyrrole derivatives.

Main Methods:

  • Synthesis of novel 3-heteroaryl-pyrroles.
  • Evaluation of diphenylpyrrole derivatives as HDM2 antagonists.
  • Chemical reactions involving E-3-(dimethylamino)-1-(2-methyl-4,5-diphenyl-1H-pyrrol-3-yl)prop-2-en-1-one and related compounds with various nucleophiles.

Main Results:

  • Successful synthesis of a new series of diphenylpyrrole compounds.
  • Demonstration of diphenylpyrroles as a viable scaffold for HDM2 antagonist development.
  • Identification of synthetic pathways for generating diverse 3-heteroaryl-pyrrole structures.

Conclusions:

  • Diphenylpyrroles represent a promising novel scaffold for developing p53-activating antitumor agents.
  • The described synthetic methods allow for the efficient generation of diverse heterocyclic derivatives.
  • Further investigation into these compounds may lead to new cancer therapies targeting the p53 pathway.
Keywords:
BenzimidazopyrimidinePyrazolopyrimidinePyrrolesTriazolopyrimidinep53-specific ubiquitin E3 ligase HDM2

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.7K
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

370

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K